Current approaches to the treatment of Parkinson's disease

269Citations
Citations of this article
455Readers
Mendeley users who have this article in their library.

Abstract

Enormous progress has been made in the treatment of Parkinson's disease (PD). As a result of advances in experimental therapeutics, many promising therapies for PD are emerging. Levodopa remains the most potent drug for controlling PD symptoms, yet is associated with significant complications such as the "wearing off" effect, levodopa-induced dyskinesias and other motor complications. Catechol-o-methyl-transferase inhibitors, dopamine agonists and nondopaminergic therapy are alternative modalities in the management of PD and may be used concomitantly with levodopa or one another. The neurosurgical treatment, focusing on deep brain stimulation, is reviewed briefly. Although this review has attempted to highlight the most recent advances in the treatment of PD, it is important to note that new treatments are not necessarily better than the established conventional therapy and that the treatment options must be individualized and tailored to the needs of each individual patient. © 2008 Dove Medical Press Limited. All rights reserved.

Cite

CITATION STYLE

APA

Jankovic, J., & Aguilar, L. G. (2008). Current approaches to the treatment of Parkinson’s disease. Neuropsychiatric Disease and Treatment. DOVE Medical Press Ltd. https://doi.org/10.2147/ndt.s2006

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free